Log in with your email address username.

×

Important notice

doctorportal Learning is on the move as we will be launching a new website very shortly. If you would like to sign up to dp Learning now to register for CPD learning or to use our CPD tracker, please email support@doctorportal.com.au so we can assist you. If you are already signed up to doctorportal Learning, your login will work in the new site so you can continue to enrol for learning, complete an online module, or access your CPD tracker report.

To access and/or sign up for other resources such as Jobs Board, Bookshop or InSight+, please go to www.mja.com.au, or click the relevant menu item and you will be redirected.

All other doctorportal services, such as Find A Doctor, are no longer available.

[Correspondence] Dual antiplatelet therapy duration and mortality

We read with great interest the Review and meta-analysis by Sammy Elmariah and colleagues (Feb 28, p 792),1 in which they suggest that prolonged duration dual antiplatelet therapy (DAPT) is not associated with a difference in the risk of cardiovascular or non-cardiovascular death, compared with aspirin alone or short duration DAPT. In contrast, results of the 2014 DAPT Study by Laura Mauri and colleagues2 showed that continuation of DAPT beyond 12 months after coronary stenting was associated with an increase in the risk of non-cardiovascular death.

email